November 2013

Preemptive Therapy of GVHD

Condition: Graft-vs-host Disease
Intervention: Drug: rabbit antithymocyte globulin
Sponsors: University of Calgary; University of Alberta; Alberta Health Services
Suspended - verified October 2016

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Condition: Sialorrhea
Interventions: Drug: MYOBLOC; Other: PLACEBO
Sponsor: US WorldMeds LLC
Completed - verified February 2017

Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)

Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Amyotrophic Lateral Sclerosis
Sponsor: University of Michigan
Recruiting - verified April 2016

Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis

Condition: Amyotrophic Lateral Sclerosis
Interventions: Procedure: ALS Patients receiving stem cells; Procedure: ALS patients not receiving stem cells
Sponsor: University of Michigan
Active, not recruiting - verified April 2016

Developing a Discrimination Model to Diagnose ALS

Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: MRI(magnetic resonance imaging)
Sponsor: University of Michigan
Completed - verified April 2016

November 2013

Preemptive Therapy of GVHD

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)

Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis

Developing a Discrimination Model to Diagnose ALS

Keep in touch

Be a team player

Learn about ALS

Get help

You are here

November 2013

Keep in touch

Be a team player

Learn about ALS

Get help